Skip to main content
. 2020 Nov 2;12(11):3230. doi: 10.3390/cancers12113230
ATRX α-thalassemia/mental retardation syndrome X-linked
BBB blood–brain barrier
BV blood vessels
CGP chemical and genetic perturbations
CL classical
FFPE formalin-fixed paraffin-embedded
CP canonical pathways
GSEA gene set enrichment analysis
GBM glioblastoma
GBMwt_hi a subgroup of IDH wild-type tumors with a high content of CD45+ cells (more than 15% of the cellular suspension)
GBMwt_lo a subgroup of IDH wild-type tumors with a low content of CD45+ cells (less than 15% of the cellular suspension)
IBA1 ionized calcium binding adaptor molecule 1
ICI immune checkpoint inhibitors
IDH1/2 isocitrate dehydrogenase 1/2
IHC immunohistochemistry
LGG lower-grade glioma
MDSC Myeloid-derived suppressor cells
MES mesenchymal
MGMT O6-methylguanine-DNA-methyltransferase
mut mutant
ns not significant
PCR polymerase chain reaction
PD-1 programmed cell death 1
PD-L1 programmed death ligand 1
PN proneural
RT room temperature
SEM standard error of the mean
TCGA the cancer genome atlas
TME tumor microenvironment
Tregs regulatory T cells
VEGF vascular endothelial growth factor
wt wild-type